News
2mon
GlobalData on MSNSupernus wins FDA approval for Parkinson’s pump on fourth trySupernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
ROCKVILLE, Md., April 23, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of ...
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus Pharmaceuticals, Inc. ("Supernus Pharmaceuticals ...
February 18, 2025 Supernus' depression treatment fails mid-stage trial, shares plunge Supernus Pharmaceuticals said on Tuesday its depression treatment trial failed to meet the main goal of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results